Related Experiment Videos
[Acute fibrinopenia in obstetrics]
R Torrielli1, F Boutin, M Rochet
1Département d'Anesthésie-Réanimation, maternité Pellegrin, Bordeaux.
Revue Francaise De Gynecologie Et D'Obstetrique
|July 1, 1988
Summary
Severe obstetrical hemorrhage management requires prompt correction of low fibrinogen levels. Early fibrinogen replacement therapy is crucial for reducing complications and improving outcomes in postpartum hemorrhage cases.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Critical Care Medicine
Context:
- Severe obstetrical hemorrhage presents diagnostic and therapeutic challenges.
- Understanding the pathophysiology of postpartum hemorrhage is critical for effective management.
- This review examines 10 cases of severe obstetrical bleeding.
Purpose:
- To highlight the significance of fibrinogen levels in severe obstetrical hemorrhage.
- To emphasize the importance of early and aggressive fibrinogen replacement therapy.
- To provide guidance on managing acute obstetric bleeding, including contraindications for heparin.
Summary:
- Severe obstetrical hemorrhage is characterized by a rapid and significant drop in fibrinogen levels.
- Fibrinogen levels below 1 g/L in 20% and 0.5 g/L in 50% of cases indicate severe bleeding.
- Early administration of fractionated fibrinogen (mean dose 3 g) is essential for treatment.
- Heparin therapy should be avoided during the acute phase to prevent exacerbating hemorrhage.
Impact:
- Prompt fibrinogen administration can reduce the duration of obstetrical hemorrhage and minimize complications.
- This approach can improve patient outcomes in cases of severe postpartum bleeding.
- Highlights the critical role of timely hematological support in obstetric emergencies.